Coherus BioSciences, Inc. (Coherus, NASDAQ: CHRS) today announced the launch of UDENYCA ONBODY™, the company’s on-body injector (OBI)...
Febrile Neutropenia
Investigational drugs opaganib and RHB-107 (upamostat) demonstrate distinct synergistic effect when combined individually with remdesivir, significantly improving...
Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that the new drug application of...
